trial · primary record
Teclistamab
Multiple Myeloma
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 1590 |
| Primary completion | 2033-10-28 |
| Primary endpoint | Progression Free Survival (PFS) |
| Registry ID | NCT05552222 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:59.431Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05552222
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Teclistamab · compound